Clinical Implications of Emerging Evidence in Prostate Cancer and EGFR-Mutated NSCLC From the European Oncology Meeting Authors: Mary-Ellen Taplin, MD; Alexander I. Spira, MD, PhD, FACP, FASCO

Clinical Implications of Emerging Evidence in Prostate Cancer and EGFR-Mutated NSCLC From the European Oncology Meeting Authors: Mary-Ellen Taplin, MD; Alexander I. Spira, MD, PhD, FACP, FASCO https://www.medscape.org/viewarticle/clinical-implications-emerging-evidence-prostate-cancer-and-2026a10016q3?page=1